Kurzübersicht für Solute Carrier Family 26, Member 4 (SLC26A4) (Middle Region) Peptid (ABIN983933)
Target
SLC26A4
(Solute Carrier Family 26, Member 4 (SLC26A4))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
Protein Region
Middle Region
Produktmerkmale
This is a synthetic peptide designed for use in combination with anti-SLC26A4 antibody (Catalog #: ARP41739_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
SLC26A4
(Solute Carrier Family 26, Member 4 (SLC26A4))
Hintergrund
Mutations in this gene are associated with Pendred syndrome, the most common form of syndromic deafness, an autosomal-recessive disease. It is highly homologous to the SLC26A3 gene, they have similar genomic structures and this gene is located 3' of the S